22.05.2024 - Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that three submitted .
Lilah Morris-Wiseman aims to expand the endocrine surgery program and Comprehensive Adrenal Center. Her interests include inherited endocrine diseases and thyroid, parathyroid and adrenal surgical diseases.